Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
Renewed hope at AIDS conference for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene
Xconomy forum highlights research in vaccines, organ transplants, big data, more
A new path to an AIDS vaccine?
A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies